The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Prognostic value of proliferation in invasive breast cancer: a review: Table 1
Open accessAbstract
Breast cancer is the leading cause of death among solid tumours in women, and its incidence is increasing in the West. Adjuvant chemotherapy and hormonal treatment improve survival but have potentially serious side effects, and are costly. Because adjuvant treatment should be given to high risk patients only, and traditional prognostic factors (lymph node status, tumour size) are insufficiently accurate, better predictors of high risk and treatment response are needed. Invasive breast cancer metastasises haematogenously very early on, so many breast cancer prognosticators are directly or indirectly related to proliferation. Although studies evaluating the role of individual proliferation regulating genes have greatly increased our knowledge of this complex process, the functional end result—cells dividing—has remained the most important prognostic factor. This article reviews the prognostic value of different proliferation assays in invasive breast cancer, and concludes that increased proliferation correlates strongly with poor prognosis, irrespective of the methodology used. Mitosis counting provides the most reproducible and independent prognostic value, and Ki67/MIB1 labelling and cyclin A index are promising alternatives that need methodological fine tuning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy of screening mammography. A meta-analysis
Kerlikowske, K. M. (1995) · JAMA · doi:10.1001/jama.273.2.149 · Cited by 1,131
Prognostic Factors in Breast Cancer: College of American Pathologists Consensus Statement 1999
Fitzgibbons, P. L., Page, D. L., Weaver, D., Thor, A. D., Allred, D. C., Clark, G. M., Ruby, S. G., O'Malley, F., Simpson, J. F., Connolly, J. L., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0966-pfibc · Cited by 1,016
Thor, A. D., Moore, D. H., Edgerton, S. M., Kawasaki, E. S., Reihsaus, E., Lynch, H. T., Marcus, J. N., Schwartz, L., Chen, L.-C., Mayall, B. H., et al. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.11.845 · Cited by 723
Cochrane review on screening for breast cancer with mammography
Olsen, O., & Gøtzsche, P. C. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06449-2 · Cited by 710
Lakhani, S. R., Jacquemier, J., Sloane, J. P., Gusterson, B. A., Anderson, T. J., van de Vijver, M. J., Farid, L. M., Venter, D., Antoniou, A., Storfer-Isser, A., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.15.1138 · Cited by 707
Ki67 protein: the immaculate deception?
Brown, D. C., & Gatter, K. C. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.01343.x · Cited by 509
Bos, R., van der Groep, P., Greijer, A. E., Shvarts, A., Meijer, S., Pinedo, H. M., Semenza, G. L., van Diest, P. J., & van der Wall, E. (2003) · Cancer · doi:10.1002/cncr.11246 · Cited by 500
Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage
Marcus, J. N., Watson, P., Page, D. L., Narod, S. A., Lenoir, G. M., Tonin, P., Linder-Stephenson, L., Salerno, G., Conway, T. A., & Lynch, H. T. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960215)77:4<697::aid-cncr16>3.0.co;2-w · Cited by 454
Le Doussal, V., Tubiana-Hulin, M., Friedman, S., Hacene, K., Spyratos, F., & Brunet, M. (1989) · Cancer · doi:10.1002/1097-0142(19891101)64:9<1914::aid-cncr2820640926>3.0.co;2-g · Cited by 377
van Diest, P. J., Baak, J. P. A., Matze-Cok, P., Wisse-Brekelmans, E. C. M., van Galen, C. M., Kurver, P. H. J., Bellot, S. M., Fijnheer, J., van Gorp, L. H. M., Kwee, W. S., et al. (1992) · Human Pathology · doi:10.1016/0046-8177(92)90313-r · Cited by 353
Self-citationQuinn, C. M., & Wright, N. A. (1990) · The Journal of Pathology · doi:10.1002/path.1711600202 · Cited by 329
Gospodarowicz, M., & O'Sullivan, B. (2003) · Seminars in Surgical Oncology · doi:10.1002/ssu.10016 · Cited by 283
de Jong, J. S., van Diest, P. J., van der Valk, P., & Baak, J. P. A. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199801)184:1<53::aid-path6>3.0.co;2-7 · Cited by 257
Self-citationMirza, A. N., Mirza, N. Q., Vlastos, G., & Singletary, S. E. (2002) · Annals of Surgery · doi:10.1097/00000658-200201000-00003 · Cited by 246
Proliferation markers in tumours: interpretation and clinical value.
van Diest, P. J., Brugal, G., & Baak, J. P. (1998) · Journal of Clinical Pathology · doi:10.1136/jcp.51.10.716 · Cited by 217
Self-citationHistologic grading of breast carcinoma. A reproducibility study
Dalton, L. W., Page, D. L., & Dupont, W. D. (1994) · Cancer · doi:10.1002/1097-0142(19940601)73:11<2765::aid-cncr2820731119>3.0.co;2-k · Cited by 214
Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.
van Diest, P. J., Michalides, R. J. A. M., Jannink, L., van der Valk, P., Peterse, H. L., de Jong, J. S., Meijer, C. J. L. M., & Baak, J. P. A. (1997) · Europe PMC (PubMed Central) · Cited by 207
Self-citationBukholm, I. R. K., Bukholm, G., & Nesland, J. M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1311 · Cited by 205
Apoptosis in breast cancer as related to histopathological characteristics and prognosis
Lipponen, P., Aaltomaa, S., Kosma, V.-M., & Syrjänen, K. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)00342-3 · Cited by 195
Weidner, N., Moore II, D. H., & Vartanian, R. (1994) · Human Pathology · doi:10.1016/0046-8177(94)90140-6 · Cited by 190
Trihia, H., Murray, S., Price, K., Gelber, R. D., Golouh, R., Goldhirsch, A., Coates, A. S., Collins, J., Castiglione‐Gertsch, M., & Gusterson, B. A. (2003) · Cancer · doi:10.1002/cncr.11188 · Cited by 189
Spyratos, F., Ferrero‐Poüs, M., Trassard, M., Hacène, K., Phillips, E., Tubiana‐Hulin, M., & Le Doussal, V. (2002) · Cancer · doi:10.1002/cncr.10458 · Cited by 186
Keshgegian, A. A., & Cnaan, A. (1995) · American Journal of Clinical Pathology · doi:10.1093/ajcp/104.1.42 · Cited by 184
Pinder, S., Wencyk, P., Sibbering, D., Bell, J., Elston, C., Nicholson, R., Robertson, J., Blamey, R., & Ellis, I. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.30 · Cited by 179
Proliferation index as a prognostic marker in breast cancer
Veronese, S. M., Gambacorta, M., Gottardi, O., Scanzi, F., Ferrari, M., & Lampertico, P. (1993) · Cancer · Cited by 175
de Jong, J. S., van Diest, P. J., van der Valk, P., & Baak, J. P. A. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199801)184:1<44::aid-path984>3.0.co;2-h · Cited by 169
Self-citationChapter 11 Cell Cycle Analysis
Mitchison, J. M., & Carter, B. L. A. (1975) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)60324-6 · Cited by 158
Genestie, C., Sigal‐Zafrani, B., Asselain, B. J. R., Fourquet, A., Rozan, S., Validire, P., Vincent‐Salomon, A., & Sastre‐Garau, X. (1998) · PubMed · Cited by 151
Harris, G. C., Denley, H., Pinder, S. E., et al. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200301000-00002 · Cited by 141
Thor, A. D., Liu, S., Moore, D. H., & Edgerton, S. M. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.470 · Cited by 137
Human DNA topoisomerase II-alpha: A new marker of cell proliferation in invasive breast cancer
Lynch, B. J., Guinee, D. G., & Holden, J. A. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90256-2 · Cited by 136
Histologic Grading in Breast Cancer: Reproducibility Between Seven Pathologic Departments
Boiesen, P. (2000) · Acta Oncologica · doi:10.1080/028418600430950 · Cited by 122
Liu, S., Edgerton, S. M., Moore, D. H., & Thor, A. D. (2001) · PubMed · Cited by 122
Prognostic indicators in breast cancer‐morphometric methods
Baak, J. P. A., Kurver, P. H. J., SNOO‐NIEWLAAT, A. J. E. D., Graef, S., Makkink, B., & Boon, M. E. (1982) · Histopathology · doi:10.1111/j.1365-2559.1982.tb02727.x · Cited by 122
Self-citationExpression of Geminin as a Marker of Cell Proliferation in Normal Tissues and Malignancies
Wohlschlegel, J. A., Kutok, J. L., Weng, A. P., & Dutta, A. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64178-8 · Cited by 120
de Jong, Diest, V., & van Baak, A. A. (2000) · Histopathology · doi:10.1046/j.1365-2559.2000.00850.x · Cited by 115
Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment
Michalides, R. J. A. M., van Tinteren, H., Balkenende, A., Vermorken, J. B., Benraadt, J., Huldij, J. C., & van Diest, P. J. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600072 · Cited by 115
Chang, J. C., Powles, T. J., Allred, D. C., Ashley, S. E., Makris, A., Gregory, R. K., Osborne, C. K., & Dowsett, M. (2000) · PubMed · Cited by 115
Jensen, V., Ladekarl, M. B., Holm‐Nielsen, P., Melsen, F., & Sørensen, F. B. (1995) · The Journal of Pathology · doi:10.1002/path.1711760405 · Cited by 112
Colpaert, C., Vermeulen, P. B., Jeuris, W., et al. (2001) · The Journal of Pathology · doi:10.1002/path.829 · Cited by 108
Bcl-2 and p53 expression in node-negative breast carcinoma: A study with long-term follow-up
Barbareschi, M., Caffo, O., Veronese, S. M., Leek, R., Fina, P., Fox, S. B., Bonzanini, M., Girlando, S., Morelli, L., Eccher, C., et al. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90307-x · Cited by 107
Tsuda, H., Akiyama, F., Kurosumi, M., Sakamoto, G., Watanabe, T., & Section, J. N. S. A. S. O. B. C. (.-B. P. (1998) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/28.8.486 · Cited by 105
Number of apoptotic cells as a prognostic marker in invasive breast cancer
de Jong, J. S., van Diest, P. J., & Baak, J. P. A. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0928 · Cited by 99
Self-citationNoguchi, S., Kasugai, T., Miki, Y., Fukutomi, T., Emi, M., & Nomizu, T. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990515)85:10<2200::aid-cncr14>3.0.co;2-s · Cited by 99
van Diest, P. J., & Baak, J. P. A. (1991) · Human Pathology · doi:10.1016/0046-8177(91)90080-9 · Cited by 93
Self-citationClahsen, P. C., de Velde, C. J. H. V., Duval, C., Pallud, C., Mandard, A. M., Delobelle-Deroïde, A., van den Broek, L., & van de Vijver, M. J. (1999) · European Journal of Surgical Oncology · doi:10.1053/ejso.1999.0657 · Cited by 90
Tahan, S. R., Dieffenbach, A., Yacoub, L. K., & Neuberg, D. S. (1993) · Cancer · Cited by 85
Endl, E., Kausch, I., Baack, M., Knippers, R., Gerdes, J., & Scholzen, T. E. (2001) · The Journal of Pathology · doi:10.1002/path.978 · Cited by 80
Dettmar, P., Harbeck, N., Thomssen, C., Pache, L., Ziffer, P., Fizi, K., Jänicke, F., NATHRATH, W. B. J., Schmitt, M., Graeff, H., et al. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.261 · Cited by 80
Assessment of pathologic prognostic factors in breast core needle biopsies.
Sharifi, S., Peterson, M. K., Baum, J. K., et al. (1999) · PubMed · Cited by 71
Jannink, I., van Diest, P. J., & Baak, J. P. A. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90270-8 · Cited by 68
Self-citationBillgren, L. E. R. A.-M. A.-M. (1999) · Acta Oncologica · doi:10.1080/028418699431186 · Cited by 60
A study of interval breast cancer within the NHS breast screening programme
Cowan, W. K., Angus, B., Gray, J. C., Lunt, L. G., & Al-Tamimi, S. R. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.2.140 · Cited by 56
Prognostic and Predictive Role of Proliferation Indices in Adjuvant Therapy of Breast Cancer
Daidone, M. G., & Silvestrini, R. (2001) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003457 · Cited by 53
Ikpatt, O. F., Kuopio, T., & Collan, Y. U. (2002) · Modern Pathology · doi:10.1097/01.mp.0000021764.03552.bd · Cited by 49
The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67
Goodson, W. H., Moore, D. H., Ljung, B., Chew, K., Mayall, B. H., Smith, H. S., & Waldman, F. M. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006344010050 · Cited by 47
BECK, T. M., Weller, E. E., Weikel, W., Brumm, C., Wilkens, C., & Knapstein, P. G. (1995) · Gynecologic Oncology · doi:10.1006/gyno.1995.1104 · Cited by 45
Eng, C., Ponder, B., Murday, V. A., Easton, D. F., Stratton, M., Eeles, R. A., Sacks, N., & Watson, M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91585-7 · Cited by 45
de Jong, J. S., van Diest, P. J., Michalides, R. J. A. M., & Baak, J. P. A. (1999) · Molecular Pathology · doi:10.1136/mp.52.2.78 · Cited by 42
Self-citationBukholm, I., Bukholm, G., Holm, R., et al. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.5.368 · Cited by 39
Furuta, I., Yamada, H., Sagawa, T., & Fujimoto, S. (2000) · Gynecologic and Obstetric Investigation · doi:10.1159/000010222 · Cited by 37
Haerslev, T., & Jacobsen, G. K. (1994) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00197391 · Cited by 31
Bevilacqua, P., Verderio, P., Barbareschi, M., Bonoldi, E., Boracchi, P., Palma, P. D., & Gasparini, G. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01806494 · Cited by 19
Long-term prognostic significance of thymidine labelling index in primary breast cancer
Cooke, T., Stanton, P. D., Murray, G. D., Winstanley, J., Croton, R. S., Holt, S., & George, W. D. (1992) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80067-x · Cited by 16
Cited by
Breast Cancer Histopathology Image Analysis: A Review
Veta, M., Pluim, J. P. W., van Diest, P. J., & Viergever, M. A. (2014) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2014.2303852 · Cited by 696
Self-citationAssessment of algorithms for mitosis detection in breast cancer histopathology images
Veta, M., van Diest, P. J., Willems, S. M., Wang, H., Madabhushi, A., Cruz-Roa, A., Gonzalez, F., Larsen, A. B. L., Vestergaard, J. S., Dahl, A. B., et al. (2015) · Medical Image Analysis · doi:10.1016/j.media.2014.11.010 · Cited by 480
Self-citationCancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes
Dai, X., Xiang, L., Li, T., & Bai, Z. (2016) · Journal of Cancer · doi:10.7150/jca.13141 · Cited by 440
Stuart-Harris, R., Caldas, C., Pinder, S. E., & Pharoah, P. (2008) · The Breast · doi:10.1016/j.breast.2008.02.002 · Cited by 431
Salvi, M., Acharya, U. R., Molinari, F., & Meiburger, K. M. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.104129 · Cited by 386
Metadata
- Authors
- van Diest, P. J., van der Wall, E., & Baak, J. P. A.
- Venue
- Journal of Clinical Pathology
- Publisher
- BMJ
- Published
- 2004-06-25
- Volume
- 57
- Issue
- 7
- Pages
- 675-681
- ISSN
- 0021-9746 (ISSN-L)
- 1472-4146
- OpenAlex
- W2169160999
- Cited by
- 385
- References
- 65
- FWCI
- 7.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.